Abbott completes submission of new molecular test
23 May 2011 | By Abbott
Abbott announced it filed premarket approval applications for a new molecular diagnostic test...
List view / Grid view
News
Aesica to increase presence in Asia
23 May 2011 | By Velvet Communications
Aesica Pharmaceuticals has announced the promotion of Joe Zou to manage regional sales across Asia...
Lab21 acquires molecular diagnostics company Myconostica Ltd
23 May 2011 | By College Hill
Lab21 Limited, has announced that it has acquired Myconostica Ltd...
Preventing prostate cancer cells from ‘bodybuilding’ gives new treatment hope
20 May 2011 | By Cancer Research UK
Cancer Research scientists discover that stopping prostate cancer cells ‘bulking up’ with nutrients reduces spread of the disease...
ELIQUIS® (apixaban) approved in Europe for preventing venous thromboembolism
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
GSK and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
Amgen receives CHMP positive opinion for XGEVA(TM) (Denosumab) in the European Union
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
CHMP issues positive opinion for Merck’s VICTRELIS™ (boceprevir)
20 May 2011 | By Merck
Merck announced that the CHMP of the EMA has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS™...
Cephalon granted Temporary Restraining Order in AMRIX® patent litigation
20 May 2011 | By Cephalon Inc
The United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon and Eurand for a TRO enjoining Mylan Pharmaceuticals and Mylan from manufacturing, using and selling its cyclobenzaprine hydrochloride extended-release capsules...
European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...
Abbott statement on the FDA Advisory Committee recommendations on fenofibric acid
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
R&D into personalised medicine to receive new government investment
19 May 2011 | By Technology Strategy Board
The Technology Strategy Board and the MRC are to jointly invest over £3.7 million in seven major new research projects...
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
18 May 2011 | By Abbott
Abbott has received approval from the FDA to market its RealTime PCR test for measuring the viral load of hepatitis C...
Pfizer presents new Phase 3 data
18 May 2011 | By Pfizer
Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival...
Nexavar in combination with chemotherapy improves progression-free survival in patients with advanced breast cancer in Phase 2 study
18 May 2011 | By OGILVY PR WORLDWIDE
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. announced results from a Phase 2b trial...
